Neuroprotective Agents for Neonates with Hypoxic-Ischemic Encephalopathy.

K O'Mara, C McPherson - Neonatal Network, 2021 - connect.springerpub.com
Hypoxic-ischemic encephalopathy (HIE) remains a significant source of long-term
neurodevelopmental impairment despite overall improvements in survival without disability …
被引用次数：16 相关文章

Neuroprotective Agents for Neonates with Hypoxic-Ischemic Encephalopathy.

K O'Mara, C McPherson - Neonatal Network, 2021 - search.ebscohost.com
Hypoxic-ischemic encephalopathy (HIE) remains a significant source of long-term
neurodevelopmental impairment despite overall improvements in survival without disability …

Neuroprotective Agents for Neonates with Hypoxic-Ischemic Encephalopathy

K O'Mara, C McPherson - Neonatal network: NN, 2021 - pubmed.ncbi.nlm.nih.gov
Hypoxic-ischemic encephalopathy (HIE) remains a significant source of long-term
neurodevelopmental impairment despite overall improvements in survival without disability …

Neuroprotective Agents for Neonates with Hypoxic-Ischemic Encephalopathy.

K O'Mara, C McPherson - Neonatal Network: NN, 2021 - europepmc.org
Hypoxic-ischemic encephalopathy (HIE) remains a significant source of long-term
neurodevelopmental impairment despite overall improvements in survival without disability …

Is dexmedetomidine a potential neuroprotective agent for term neonates with hypoxic-ischemic encephalopathy?

D Surkov - Pediatric Anesthesia & Critical Care Journal …, 2019 - search.ebscohost.com
Introduction The negative impacts of standard pharmacologic sedative agents suggest that
alternative agents should be investigated. Dexmedetomidine could be the new option for …